mouse anti gb Search Results


antibody responses against hcmv gb  (Sino Biological)
93
Sino Biological antibody responses against hcmv gb
Schematic drawing of rLCMV vector design and production. (A) LCMV vector particle and encapsidated genomic segments (GP, surface glycoprotein; NP, nucleoprotein; Z, ring finger protein; L, polymerase) and genetic organization of the two encapsidated genomic segments (S, short; L, long). (B) Representation of the full-length <t>HCMV</t> <t>gB</t> open reading frame HgB(FL), the truncated isoform HgB(dCt), and the corresponding design for guinea pig CMV gB [GPgB(dCt)] expressed in vaccine vectors. Numbers represent amino acid positions, and shaded boxes represent the proposed transmembrane region of the protein. Position 773 in HgB(dCt) is an extraneous arginine residue. (C) Schematic drawing of rLCMV vaccine vector rescue, stock production, and the single-round infectious character of rLCMV-vectored vaccination.
Antibody Responses Against Hcmv Gb, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+gb/Human+cytomegalovirus+(HCMV)+Glycoprotein+B+%2F+gB+Antibody%2C+Mouse+MAb/pmc05216435-295-0-16
Average 93 stars, based on 1 article reviews
antibody responses against hcmv gb - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
mouse anti mdv gb monoclonal antibody  (ScyTek Inc)
90
ScyTek Inc mouse anti mdv gb monoclonal antibody
Schematic drawing of rLCMV vector design and production. (A) LCMV vector particle and encapsidated genomic segments (GP, surface glycoprotein; NP, nucleoprotein; Z, ring finger protein; L, polymerase) and genetic organization of the two encapsidated genomic segments (S, short; L, long). (B) Representation of the full-length <t>HCMV</t> <t>gB</t> open reading frame HgB(FL), the truncated isoform HgB(dCt), and the corresponding design for guinea pig CMV gB [GPgB(dCt)] expressed in vaccine vectors. Numbers represent amino acid positions, and shaded boxes represent the proposed transmembrane region of the protein. Position 773 in HgB(dCt) is an extraneous arginine residue. (C) Schematic drawing of rLCMV vaccine vector rescue, stock production, and the single-round infectious character of rLCMV-vectored vaccination.
Mouse Anti Mdv Gb Monoclonal Antibody, supplied by ScyTek Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+gb/mouse+anti+mdv+gb+monoclonal+antibody/pmc10055809-111-5-21
Average 90 stars, based on 1 article reviews
mouse anti mdv gb monoclonal antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
viral glycoprotein b gb  (Bio-Rad)
93
Bio-Rad viral glycoprotein b gb
Schematic drawing of rLCMV vector design and production. (A) LCMV vector particle and encapsidated genomic segments (GP, surface glycoprotein; NP, nucleoprotein; Z, ring finger protein; L, polymerase) and genetic organization of the two encapsidated genomic segments (S, short; L, long). (B) Representation of the full-length <t>HCMV</t> <t>gB</t> open reading frame HgB(FL), the truncated isoform HgB(dCt), and the corresponding design for guinea pig CMV gB [GPgB(dCt)] expressed in vaccine vectors. Numbers represent amino acid positions, and shaded boxes represent the proposed transmembrane region of the protein. Position 773 in HgB(dCt) is an extraneous arginine residue. (C) Schematic drawing of rLCMV vaccine vector rescue, stock production, and the single-round infectious character of rLCMV-vectored vaccination.
Viral Glycoprotein B Gb, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+gb/Mouse+anti+Cytomegalovirus+gB+Late+Cytoplasmic+Antigen/pm40259057-51-38-46
Average 93 stars, based on 1 article reviews
viral glycoprotein b gb - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
rat anti-mouse cd68 monoclonal antibody [clone gb-22]  (Creative BioMart)
N/A
Rat anti mouse CD68 antibody, clone GB-22 recognizes mouse macrosialin, a heavily glycosylated transmembrane protein and murine homolog of human CD68, which is classified as a unique scavenger receptor (ScR) family member, due to the
   Buy from Supplier
mouse anti-cmv gb late neutralizing ag  (RayBiotech inc)
N/A
Mouse Anti-CMV gB Late Neutralizing Ag.
   Buy from Supplier
mouse anti-cmv gb late neutralizing ag.  (RayBiotech)
N/A
Mouse Anti-CMV gB Late Neutralizing Ag.
   Buy from Supplier
mouse anti-cmv gb late cytoplasmic ag.  (RayBiotech)
N/A
Mouse Anti-CMV gB Late Cytoplasmic Ag.
   Buy from Supplier
mouse anti cytomegalovirus gb late neutralizing antigen  (Bio-Rad)
N/A
   Buy from Supplier
mouse anti-cmv gb late cytoplasmic ag  (RayBiotech inc)
N/A
Mouse Anti-CMV gB Late Cytoplasmic Ag.
   Buy from Supplier

Image Search Results


Schematic drawing of rLCMV vector design and production. (A) LCMV vector particle and encapsidated genomic segments (GP, surface glycoprotein; NP, nucleoprotein; Z, ring finger protein; L, polymerase) and genetic organization of the two encapsidated genomic segments (S, short; L, long). (B) Representation of the full-length HCMV gB open reading frame HgB(FL), the truncated isoform HgB(dCt), and the corresponding design for guinea pig CMV gB [GPgB(dCt)] expressed in vaccine vectors. Numbers represent amino acid positions, and shaded boxes represent the proposed transmembrane region of the protein. Position 773 in HgB(dCt) is an extraneous arginine residue. (C) Schematic drawing of rLCMV vaccine vector rescue, stock production, and the single-round infectious character of rLCMV-vectored vaccination.

Journal: Clinical and Vaccine Immunology : CVI

Article Title: Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector

doi: 10.1128/CVI.00300-16

Figure Lengend Snippet: Schematic drawing of rLCMV vector design and production. (A) LCMV vector particle and encapsidated genomic segments (GP, surface glycoprotein; NP, nucleoprotein; Z, ring finger protein; L, polymerase) and genetic organization of the two encapsidated genomic segments (S, short; L, long). (B) Representation of the full-length HCMV gB open reading frame HgB(FL), the truncated isoform HgB(dCt), and the corresponding design for guinea pig CMV gB [GPgB(dCt)] expressed in vaccine vectors. Numbers represent amino acid positions, and shaded boxes represent the proposed transmembrane region of the protein. Position 773 in HgB(dCt) is an extraneous arginine residue. (C) Schematic drawing of rLCMV vaccine vector rescue, stock production, and the single-round infectious character of rLCMV-vectored vaccination.

Article Snippet: Antibody responses against HCMV gB in mouse sera were measured by indirect ELISA using recombinant gB (Sino Biological) as coating antigen on 96-well microplates (0.5 μg/ml, 100 μl per well, overnight at 4°C) and a goat HRP-conjugated anti-mouse IgG polyclonal secondary antibody (Jackson ImmunoResearch).

Techniques: Plasmid Preparation

rLCMV vector characterization. (A) Growth kinetics of rLCMV vectors and LCMV wild-type virus in the production cell line 293-GP. Titers represent means of 2 independent experiments, with standard deviations shown as error bars. (B) rLCMV-gB(dCt) was selected as the representative vector to demonstrate deficiency in formation of infectious progeny in cells that do not provide LCMV GP protein in trans (293F). All cell types were infected with 0.001 FFU/cell. Samples for individual time points were analyzed by means of a FFU assay based on LCMV GP-complementing 293T cells. Dotted lines indicate detection limits of the FFU assay. (C) gB(dCt) and pp65 vaccine antigen expression levels were analyzed by Western blotting. HCMV gB and HCMV pp65-specific MAbs were used to detect vaccine antigen expression, and a polyclonal anti-LCMV serum reactive with LCMV NP was used for the infection/loading control.

Journal: Clinical and Vaccine Immunology : CVI

Article Title: Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector

doi: 10.1128/CVI.00300-16

Figure Lengend Snippet: rLCMV vector characterization. (A) Growth kinetics of rLCMV vectors and LCMV wild-type virus in the production cell line 293-GP. Titers represent means of 2 independent experiments, with standard deviations shown as error bars. (B) rLCMV-gB(dCt) was selected as the representative vector to demonstrate deficiency in formation of infectious progeny in cells that do not provide LCMV GP protein in trans (293F). All cell types were infected with 0.001 FFU/cell. Samples for individual time points were analyzed by means of a FFU assay based on LCMV GP-complementing 293T cells. Dotted lines indicate detection limits of the FFU assay. (C) gB(dCt) and pp65 vaccine antigen expression levels were analyzed by Western blotting. HCMV gB and HCMV pp65-specific MAbs were used to detect vaccine antigen expression, and a polyclonal anti-LCMV serum reactive with LCMV NP was used for the infection/loading control.

Article Snippet: Antibody responses against HCMV gB in mouse sera were measured by indirect ELISA using recombinant gB (Sino Biological) as coating antigen on 96-well microplates (0.5 μg/ml, 100 μl per well, overnight at 4°C) and a goat HRP-conjugated anti-mouse IgG polyclonal secondary antibody (Jackson ImmunoResearch).

Techniques: Plasmid Preparation, Infection, Expressing, Western Blot